Responding to Unsolicited Requests for Off-Label Information: Pharma Citizen Petition Calls for New Regulations
A conversation with Darshan Kulkarni, Principal Attorney, Kulkarni LLC, focusing on the recent Citizen Petition filed with the FDA by seven major pharmaceutical companies asking for new regulations regarding the dissemination of off-label product information and other communications with healthcare professionals.
The Digital Health Coalition: Solving Real Problems — Mission Possible?
A conversation with Mark Bard, founder of the Digital Health Coalition, regarding the mission of the Coalition and what companies and individuals are involved.
Challenges of Regulating Mobile Medical Apps: Legal and Regulatory Issues You Should Know About
A conversation with Joseph Kim, MD, MPH, VP of Medical Affairs and Technology at Medical Communications Media, Inc., about the rapid development of mobile medical applications and the legal and regulatory issues that physicians, patients, and pharma developers/sponsors should be aware of.
Patient Advocates Take On the FDA: FAMEDS & Genentech Fight for Avastin
A conversation with Terrence Kalley, founder of Freedom of Access to Medicines (FAMEDS), regarding patient advocacy and his organization's fight against FDA's plans to remove the metastatic breast cancer indication for Avastin, a biologic drug produced and marketed by Genentech/Roche.
Implications of Facebook’s Page Commenting Changes
A conversation with Matthew Snodgrass, Social Media Director at WCG, about Facebook's planned changes to its
Mining Mobile Health App User Data: Liberating Health Data While Protecting Privacy
A conversation with Jacqueline Thong, co-founder and CEO of Ubiqi Health, about disease management mobile applications and how pharma marketers can leverage mobile health apps to engage with and learn from patients.
WEGO Health Activists’ View of Social Media Regulation Issues: Highlights from a 2011 survey...
A conversation with Jack Barrette, CEO and Founder of WEGO Health, providing feedback, context and prospective on an updated 2011 WEGO Health survey of
Physicians Favor Brands with Compelling Adherence Platform: Highlights of Physician Survey
A conversation with Katrina S. Firlik, M.D., Chief Medical Officer, and John Ruvane, Vice President, Sales and Business Development, HealthPrize, highlighting results of an independent physician survey that suggests HealthPrize's patient adherence program can sway physician prescribing preferences.
Patient Behavioral Coaching: An Innovative McKesson Patient Adherence Solution
A conversation with Stacey Irving, Senior Director, Channel Marketing, and Derek Rago, VP Marketing & Strategy, at McKesson Patient Relationship Solutions, about the McKesson Pharmacy Intervention Program, which expands patient access to one-on-one behavioral coaching about the importance of taking medicines from retail pharmacists in the McKesson network.
Evidence-Based Pharma Marketing: Using Science to Demonstrate Product Value
A conversation with Preeti Pinto, Principal at Preeti Pinto Consulting, LLC and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca US, about the use of comparative effectiveness and health outcomes data in the support of drug promotion to physicians, payers, and consumers.
